HIGHLIGHTS
- who: Fei Xu et al. from the Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China have published the research: Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC, in the Journal: Oxidative Medicine and Cellular Longevity 1.0 of 25/07/2022
- what: The authors got the mutation cluster as a new research unit using the Random Walks with Restarts algorithm that is used to describe the efficient boundary of mutation influences . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.